• Nenhum resultado encontrado

[PDF] Top 20 Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Has 10000 "Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis." found on our website. Below are the top 20 most common "Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.".

Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

... stage of the included patients was not homogeneous: Zhu et ...studied patients with early-stage disease, and Li et ...ELISA analysis on blood samples; another four studies ... See full document

13

Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.

... features of the nine included studies are summarized in Table 1. A total of 1203 patients with a median of 98 (range: 21–309) were ...Brazil), and one from Europe ... See full document

15

Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis.

Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis.

... features of the 9 eligible studies are listed in Table ...Japan and 1 from Switzerland. Furthermore, 2 studies focused on pancreatic cancer, 4 focused on colorectal cancer, ... See full document

8

Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.

Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.

... formation of new blood vessels from the endothelium of existing vasculature, plays a pivotal role in tumor growth, progression and metastasis ...series of angiogenic factors are ... See full document

14

Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer.

Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer.

... In lung cancer, the high incidence of local aggressiveness and metastatic behavior is one of the main causes of cancer-related mortality and may lead to ... See full document

15

The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.

The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.

... Lung cancer is the leading cause of cancer-related death all over the world during the past few ...years. Non-small cell lung cancer (NSCLC) represents the ... See full document

13

Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

... Publication and reporting bias also has to be ...only in full publications. Another potential source of bias is related to the method used to extrapolate the ...included in the article or ... See full document

8

The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.

The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.

... role in the survival of cancer cells in breast, prostate, ovary, and brain tissue ...survival of NSCLC cell [29]. Recently, a clinical study of p-AKT ... See full document

6

Chemotherapy plus best supportive care versus best supportive care in patients with non-small cell lung cancer: a meta-analysis of randomized controlled trials.

Chemotherapy plus best supportive care versus best supportive care in patients with non-small cell lung cancer: a meta-analysis of randomized controlled trials.

... purpose of undertaking this review was to determine whether chemotherapy plus BSC would improve survival, and to present all available evidence in a systematic, quantitative and ... See full document

9

Incidence and imaging characteristics of skeletal metastases detected by bone scintigraphy in lung cancer patients

Incidence and imaging characteristics of skeletal metastases detected by bone scintigraphy in lung cancer patients

... 16. Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with ... See full document

5

THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.

THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.

... quality of life benefits, but overall 2- year survival rates for this group remain <15% ...rate of 19- 32% and a me- dian survival time of 7,9 to 11,3 months ...ence in ... See full document

5

Prognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: a systematic review and meta-analysis.

Prognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: a systematic review and meta-analysis.

... group with positive LVI, relative to the reference group. The impact of LVI on outcome was considered statistically significant if the 95% CI did not overlap with 1 and if ...estimate ... See full document

9

Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country.

Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country.

... variation of efficacy of tumor cell vaccine raised a question of whether and to what extent is the T cell immunity provoked by systemic injection of tumor cell ... See full document

7

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.

... response and survival for patients whose tumors express NY-ESO-1 were not the result of increased cytotoxicity, but rather were mediated through immunological ...stimulator of T-Cells ... See full document

8

Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis.

Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis.

... thrombosis and pulmonary embolism, is the third most common circulatory disorder in Western populations, and in the United States alone is responsible for an estimated 300,000 deaths annually ... See full document

19

Selenium and lung cancer: a systematic review and meta analysis.

Selenium and lung cancer: a systematic review and meta analysis.

... or in combination vitamin E had no significant effect on the risk of developing lung cancer in a setting of primary prevention: selenium, HR ...conducted in 35,533 men ... See full document

10

Estadiamentos pré-operatório e patológico do CPNPC: análise retrospectiva de 291 casos.

Estadiamentos pré-operatório e patológico do CPNPC: análise retrospectiva de 291 casos.

... involvement of mediastinal lymph nodes, as well as the detection of pleural effusion and/or pleural implants or distant metastatic disease, usually precludes radical surgical proce- ...selection ... See full document

5

PDF EN Jornal Brasileiro de Pneumologia 3 1 english

PDF EN Jornal Brasileiro de Pneumologia 3 1 english

... use of TMA blocks have shown various advantages compared to that of traditional sections: savings of time and reagents required to perform the reactions; standardization of reactions; ... See full document

2

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

... consecutive patients who underwent curative pulmonary resection at the Medical University of Gdansk (Gdansk, Poland) between 2000 and 2004, after obtaining approval from the institutional ... See full document

7

Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.

Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.

... (RCT) with voluntarily enrolled patients; (2) patients had histologically or cytologically confirmed NSCLC and had been diagnosed with multiple brain metastases using CT or MRI; ... See full document

6

Show all 10000 documents...